Edition:
United States

CSL Ltd (CSL.AX)

CSL.AX on Australia Stock Exchange

114.60AUD
20 Jan 2017
Change (% chg)

$3.10 (+2.78%)
Prev Close
$111.50
Open
$111.92
Day's High
$115.99
Day's Low
$111.92
Volume
2,285,347
Avg. Vol
1,003,851
52-wk High
$121.25
52-wk Low
$91.62

CSL.AX

Chart for CSL.AX

About

CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment... (more)

Overall

Beta: 0.80
Market Cap(Mil.): $45,168.09
Shares Outstanding(Mil.): 455.69
Dividend: 0.89
Yield (%): 1.72

Financials

  CSL.AX Industry Sector
P/E (TTM): 27.96 29.93 30.76
EPS (TTM): 3.55 -- --
ROI: 21.32 15.46 14.89
ROE: 46.76 16.64 16.30

Australia shares rise as CSL surges, materials gain; NZ flat

Jan 19 CSL Ltd drove gains in the Australian benchmark on Thursday, surging after it upgraded its annual profit guidance, while materials and financials also added to the uptrend.

Jan 18 2017

BRIEF-CSL closed new US$550 mln private placement in US

* On 13 October 2016 it closed a new USD550 million private placement in US

Oct 13 2016

BRIEF-Dundee Acquisition & CHC Student Housing Announce Proposed Business Combination

* Dundee Acquisition Ltd. And CHC Student Housing Corp. Announce proposed business combination and series of student housing property acquisitions to create Canadian Student Living Group Inc.

Aug 25 2016

Earnings vs. Estimates